Trial
NCT04083898
Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Washington University School of Medicine
Collaborators
Sanofi
Condition
Multiple Myeloma
Intervention
Isatuximab
Why stopped
Decision made to not move forward with Phase II portion of trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-19